Invention Grant
- Patent Title: Natriuretic peptide receptor 1 antibodies and methods of use
-
Application No.: US16897935Application Date: 2020-06-10
-
Publication No.: US11066469B2Publication Date: 2021-07-20
- Inventor: John Louis Diener , Lars Gadtke , Felix Hartlepp , Kathrin Ladetzki-Baehs , Michael Romanowski , Cesare Russo , Xenia Wezler
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Meghan S. Adams
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61P9/00 ; A61P13/12 ; C07K14/72 ; A61K45/06 ; A61K39/00 ; C07K14/58
Abstract:
This disclosure relates to anti-Natriuretic Peptide Receptor 1 (NPR1) antibodies including agonist antibodies which are able to activate the NPR1 receptor, pharmaceutical compositions comprising the same, and methods of treatment comprising the same.
Information query
